Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Age-group-specific trend analyses of oropharyngeal squamous cell carcinoma incidence from 1989 to 2018 and risk factors profile by age-group in 2015-2018: a population-based study in The Netherlands.
Al-Jamaei AAH, Helder MN, Forouzanfar T, Brakenhoff RH, Leemans CR, de Visscher JGAM, van Dijk BAC. Al-Jamaei AAH, et al. Among authors: helder mn. Eur J Cancer Prev. 2022 Mar 1;31(2):158-165. doi: 10.1097/CEJ.0000000000000678. Eur J Cancer Prev. 2022. PMID: 34267108 Review.
Advances in Bioprinting Technologies for Craniofacial Reconstruction.
Visscher DO, Farré-Guasch E, Helder MN, Gibbs S, Forouzanfar T, van Zuijlen PP, Wolff J. Visscher DO, et al. Among authors: helder mn. Trends Biotechnol. 2016 Sep;34(9):700-710. doi: 10.1016/j.tibtech.2016.04.001. Epub 2016 Apr 21. Trends Biotechnol. 2016. PMID: 27113634 Review.
A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
Haghiralsadat F, Amoabediny G, Helder MN, Naderinezhad S, Sheikhha MH, Forouzanfar T, Zandieh-Doulabi B. Haghiralsadat F, et al. Among authors: helder mn. Artif Cells Nanomed Biotechnol. 2018 Feb;46(1):169-177. doi: 10.1080/21691401.2017.1304403. Epub 2017 Apr 4. Artif Cells Nanomed Biotechnol. 2018. PMID: 28376641
A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines.
Haghiralsadat F, Amoabediny G, Sheikhha MH, Forouzanfar T, Helder MN, Zandieh-Doulabi B. Haghiralsadat F, et al. Among authors: helder mn. Cell J. 2017 Spring;19(Suppl 1):55-65. doi: 10.22074/cellj.2017.4502. Epub 2017 May 17. Cell J. 2017. PMID: 28580308 Free PMC article.
EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment.
Haghiralsadat F, Amoabediny G, Naderinezhad S, Nazmi K, De Boer JP, Zandieh-Doulabi B, Forouzanfar T, Helder MN. Haghiralsadat F, et al. Among authors: helder mn. Pharm Res. 2017 Dec;34(12):2891-2900. doi: 10.1007/s11095-017-2272-6. Epub 2017 Nov 6. Pharm Res. 2017. PMID: 29110283
Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.
Haghiralsadat F, Amoabediny G, Naderinezhad S, Forouzanfar T, Helder MN, Zandieh-Doulabi B. Haghiralsadat F, et al. Among authors: helder mn. Artif Cells Nanomed Biotechnol. 2018;46(sup1):684-692. doi: 10.1080/21691401.2018.1434533. Epub 2018 Feb 23. Artif Cells Nanomed Biotechnol. 2018. PMID: 29475393
148 results